BCL2L11 and lung cancer: Costa et al. found that the upregulation of BIM correlated with gefitinib-induced apoptosis of EGFR-mutant lung cancer cells while knockdown of BIM blocked the apoptosis, indicating that BIM mediated TKI-induced apoptosis in lung cancer [17].